Align Technology, Inc. ALGN
- Market cap
- $10.4B
- P/E
- 25.5×
Follow ALGN
Align Technology, Inc. (ALGN) Return on invested capital
Align Technology, Inc.'s return on invested capital over the twelve months to 30 June 2026 was 10.9%, down 0.6 percentage points from fiscal 2025 (11.6%). Over the past ten years it has ranged from 10.7% (fiscal 2020) to 71.0% (fiscal 2019); the current reading is higher than 18% of that period. That is above the Medical Instruments & Supplies industry median of 0.00% and above the Healthcare sector median of 0.00%.
Return on invested capital, annual
Annual
| Period | Return on invested capital | Change (points) |
|---|---|---|
| FY2025 | 11.6% | (1.97) |
| FY2024 | 13.5% | (1.61) |
| FY2023 | 15.1% | (0.31) |
| FY2022 | 15.4% | (9.45) |
| FY2021 | 24.9% | 14.24 |
| FY2020 | 10.7% | (60.35) |
| FY2019 | 71.0% | 14.66 |
| FY2018 | 56.3% | 5.27 |
| FY2017 | 51.1% | 7.26 |
| FY2016 | 43.8% | 7.04 |
Against its own ten years
Return on invested capital against peers
| Company | Return on invested capital |
|---|---|
| SOLV Solventum Corporation compare | 13.4% |
| ALGN Align Technology, Inc. | 10.9% |
| ATR AptarGroup, Inc. compare | 7.82% |
| STVN Stevanato Group S.p.A. compare | 6.56% |
| COO The Cooper Companies, Inc. compare | 3.17% |
| RGEN Repligen Corporation compare | 2.18% |
| BLCO Bausch + Lomb Corporation compare | 1.81% |
| BAX Baxter International Inc. compare | −1.27% |
| AVTR Avantor, Inc. compare | −2.09% |
| Medical Instruments & Supplies industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Return on invested capital is
Return on Invested Capital shows how much after-tax operating profit a company earns on the money its lenders and shareholders have put in.
TTM: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) (latest quarter) + Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter) − Cash & Short Term Investments (latest quarter)); Annual: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) + Long Term Debt (Total) + Current Part of Debt − Cash & Short Term Investments)
More on ALGN
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement